HK Stock Movement | ADICON HOLDINGS (09860) Rises Over 8% in Early Trading as AI Giants Vie for AI Healthcare Market; Domestic AI Medical Applications Lead in Practice

Stock News
01/12

ADICON HOLDINGS (09860) surged more than 8% during the morning session. As of the time of writing, the stock was up 6.38%, trading at HK$5, with a turnover of HK$5.2193 million. On the news front, according to media reports, OpenAI announced the launch of ChatGPT Health, a model integrated into ChatGPT that serves as a "dedicated, separate space for health-related conversations with ChatGPT." It can connect to electronic medical records and various health applications, generating responses that incorporate users' health information and personal context. Just days after OpenAI announced new tools for clinicians, Anthropic stated on Sunday local time that its chatbot, Claude, will introduce new healthcare services compliant with the HIPAA standard, allowing hospitals, healthcare providers, and consumers to use the service for handling protected health data. Anthropic has also integrated scientific databases into its product and enhanced its capabilities for biological research. It is understood that currently, domestic AI medical application practices are already at the forefront. Ant Group's "A-Fu" App saw its monthly active users quickly double to 30 million after a brand upgrade, with daily inquiries exceeding 10 million. The key to its success lies in integrating a full chain of services from health consultation to online appointment booking and medical insurance payments, effectively reaching lower-tier markets. Previously, ADICON HOLDINGS launched the "Ai Xiao Yi" intelligent assistant for doctors, providing one-stop services including test recommendations, intelligent consultation, report interpretation, and professional Q&A. Concurrently, it is deploying the medical AI large model "Wen Yi" to strengthen clinical decision support and multi-modal data integration capabilities.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10